Teva Pharmaceutical Industries Profit Margin 2006-2018 | TEVA

Current and historical gross margin, operating margin and net profit margin for Teva Pharmaceutical Industries (TEVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Teva Pharmaceutical Industries net profit margin as of September 30, 2018 is -54.67%.
Teva Pharmaceutical Industries Annual Profit Margins
Teva Pharmaceutical Industries Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $22.371B $22.385B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.630B 9.04
Mylan (MYL) United Kingdom $17.841B 7.35
Bausch Health Cos (BHC) Canada $8.219B 5.95
Dr Reddy's Laboratories (RDY) India $5.845B 23.34
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.568B 4.28
Supernus Pharmaceuticals (SUPN) United States $2.211B 20.95
Amphastar Pharmaceuticals (AMPH) United States $0.945B 102.55
Akorn (AKRX) United States $0.851B 0.00
Homology Medicines (FIXX) United States $0.720B 0.00
Assembly Biosciences (ASMB) United States $0.622B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.439B 0.00
Voyager Therapeutics (VYGR) United States $0.377B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Teligent (TLGT) United States $0.117B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.089B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Acasti Pharma (ACST) Canada $0.053B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00